Buffett watchers cheer Berkshire's Apple and UnitedHealth bets — but wonder why he's sitting on so much cash

Warren Buffett's Berkshire Hathaway significantly adjusted its portfolio last quarter, initiating a $1.6 billion stake in embattled UnitedHealth (UNH), viewed by analysts as a classic value play despite its regulatory and leadership challenges, while further trimming its highly profitable Apple (AAPL) position. Concurrently, Berkshire increased its cash pile to a record $344 billion and sold a net $3 billion in stocks, but notably abstained from share buybacks, surprising some observers given the company's substantial cash reserves and potential for large-scale acquisitions or shareholder returns.

Analysis

Berkshire Hathaway's latest portfolio update reveals a strategic pivot, characterized by a significant new contrarian investment and continued profit-taking in its largest holding. The firm initiated a $1.6 billion stake in UnitedHealth, an embattled insurer whose stock has fallen nearly 50% over the past year amid regulatory and leadership crises. This move is viewed by analysts as a classic value play, capitalizing on what is perceived as a temporary, reputation-driven undervaluation of a well-entrenched industry leader. In contrast, Berkshire continued to reduce its Apple position, selling down its stake to $57 billion after realizing monumental gains. This trim is described as a 'prudent' decision based on the view that Apple's valuation is stretched relative to its growth rate. Beyond these specific trades, Berkshire's broader strategy signals caution; the company sold a net $3 billion of stocks and increased its cash reserves to a record $344 billion. Notably, it abstained from any share buybacks during the quarter, a move that surprised analysts, especially as Berkshire's own stock experienced a 13% decline during part of the period, suggesting management did not view the shares as undervalued and is preserving capital for potentially large acquisitions should market conditions become more favorable.

Key Decisions for Investors

• Investors may interpret Berkshire's contrarian investment in UnitedHealth as a signal that the insurer's fundamental franchise value is being significantly underestimated by the market due to its current regulatory and reputational headwinds.
• The continued and substantial reduction of the Apple stake by a premier value investor suggests that shareholders should critically reassess Apple's current valuation relative to its growth prospects and consider trimming positions to realize gains.
• Berkshire's record $344 billion cash position and halt in share repurchases act as a cautionary indicator for broad market valuations, suggesting it may be prudent for investors to exercise discipline and maintain liquidity for future buying opportunities.